FR2382450B1 - - Google Patents

Info

Publication number
FR2382450B1
FR2382450B1 FR7806161A FR7806161A FR2382450B1 FR 2382450 B1 FR2382450 B1 FR 2382450B1 FR 7806161 A FR7806161 A FR 7806161A FR 7806161 A FR7806161 A FR 7806161A FR 2382450 B1 FR2382450 B1 FR 2382450B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7806161A
Other versions
FR2382450A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cytiva Sweden AB
Original Assignee
Pharmacia Fine Chemicals AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Fine Chemicals AB filed Critical Pharmacia Fine Chemicals AB
Publication of FR2382450A1 publication Critical patent/FR2382450A1/fr
Application granted granted Critical
Publication of FR2382450B1 publication Critical patent/FR2382450B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/06—Enzymes or microbial cells immobilised on or in an organic carrier attached to the carrier via a bridging agent
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/70—Sulfur atoms
    • C07D213/71—Sulfur atoms to which a second hetero atom is attached
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pyridine Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Polyamides (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7806161A 1977-03-04 1978-03-03 Produits composes de la pyridine et leur application comme agents de liaison bifonctionnels et comme agents de formation de thiols Granted FR2382450A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7702462A SE430062B (sv) 1977-03-04 1977-03-04 Kopplings- eller tioleringsreagens

Publications (2)

Publication Number Publication Date
FR2382450A1 FR2382450A1 (fr) 1978-09-29
FR2382450B1 true FR2382450B1 (fr) 1982-11-05

Family

ID=20330623

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7806161A Granted FR2382450A1 (fr) 1977-03-04 1978-03-03 Produits composes de la pyridine et leur application comme agents de liaison bifonctionnels et comme agents de formation de thiols

Country Status (6)

Country Link
US (1) US4149003A (fr)
JP (2) JPS53130674A (fr)
DE (1) DE2808523A1 (fr)
FR (1) FR2382450A1 (fr)
GB (1) GB1597756A (fr)
SE (1) SE430062B (fr)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2430943A1 (fr) * 1978-07-13 1980-02-08 Toyo Jozo Kk Nouveaux derives disulfures
SE446184B (sv) * 1979-01-12 1986-08-18 Toyo Jozo Kk Polyfunktionell disulfidforening anvendbar som tverbindande medel
SE8003732L (sv) * 1980-05-19 1981-11-20 Pharmacia Diagnostics Ab Sett vid bestemningsmetoder involverande biospecifika affinitetsreaktioner
US4563304A (en) * 1981-02-27 1986-01-07 Pharmacia Fine Chemicals Ab Pyridine compounds modifying proteins, polypeptides or polysaccharides
SE8102193L (sv) * 1981-04-06 1982-10-07 Pharmacia Ab Terapeutiskt aktiv organisk forening och dess anvendning
SE8102194L (sv) * 1981-04-06 1982-10-07 Pharmacia Ab Terapeutiskt aktiv organisk forening och farmaceutisk beredning innehallande denna
US4433059A (en) * 1981-09-08 1984-02-21 Ortho Diagnostic Systems Inc. Double antibody conjugate
FR2522269A1 (fr) * 1982-02-26 1983-09-02 Pasteur Institut Agents antitumoraux, tels que la daunorubicine, a efficacite amelioree, leur obtention et procede pour augmenter l'efficacite des agents antitumoraux
FR2523445A1 (fr) * 1982-03-17 1983-09-23 Sanofi Sa Nouveaux conjugues associant, par liaison covalente, une enzyme et un anticorps, et associations medicamenteuses utilisant lesdits conjugues
US4614712A (en) * 1983-02-25 1986-09-30 The Upjohn Company Immunoassays with luciferase labeled ligands or receptors
SE8302758L (sv) * 1983-05-17 1984-11-18 Pharmacia Ab Sett for uppspjelkning av disulfidbindningar och derigenom erhallen forening
GB8334499D0 (en) * 1983-12-24 1984-02-01 Beecham Group Plc Derivatives
ATE107031T1 (de) * 1984-12-03 1994-06-15 Hoechst Celanese Corp Verfahren zur bestimmung eines liganden.
US4797491A (en) * 1986-03-17 1989-01-10 Cetus Corporation Compound 1-(3-(2-pyridyldithio)propionamido)-12-(5-hydrazidoglutaramido)-4,9-dioxadodecane
US4880935A (en) * 1986-07-11 1989-11-14 Icrf (Patents) Limited Heterobifunctional linking agents derived from N-succinimido-dithio-alpha methyl-methylene-benzoates
JPS6391563A (ja) * 1986-10-07 1988-04-22 Nitsusui Seiyaku Kk 細菌由来蛋白特異抗原の検査法
US4709037A (en) * 1987-02-17 1987-11-24 Hoechst Celanese Corporation Biotinylating agents
US4794082A (en) * 1987-02-17 1988-12-27 Hoechst Celanese Corporation Biotinylating agents
US4798795A (en) * 1987-02-17 1989-01-17 Hoechst Celanese Corporation Biotinylating agents
JPS63189278U (fr) * 1987-05-28 1988-12-05
DE3809986A1 (de) * 1988-03-24 1989-10-05 Boehringer Mannheim Gmbh Verbindungen zur einfuehrung einer sh-gruppe in tyrosin
JPH0253770U (fr) * 1988-10-12 1990-04-18
JP2619549B2 (ja) * 1989-06-29 1997-06-11 日本商事株式会社 抗原の定量法およびそれに用いる固相
US5137877B1 (en) * 1990-05-14 1996-01-30 Bristol Myers Squibb Co Bifunctional linking compounds conjugates and methods for their production
WO1992001938A1 (fr) * 1990-07-20 1992-02-06 City Of Hope Derivatisation de proline a terminaison c
US5516703A (en) * 1993-08-20 1996-05-14 The University Of Utah Coating of hydrophobic surfaces to render them protein resistant while permitting covalent attachment of specific ligands
US6284503B1 (en) 1993-08-20 2001-09-04 University Of Utah Research Foundation Composition and method for regulating the adhesion of cells and biomolecules to hydrophobic surfaces
US6552060B1 (en) 1997-08-11 2003-04-22 Prolx Pharmaceuticals, Inc. Asymmetric disulfides and methods of using same
US20030176512A1 (en) * 1998-08-11 2003-09-18 Kirkpatrick D. Lynn Asymmetric disulfides and methods of using same
AR030612A1 (es) * 2000-09-12 2003-08-27 Smithkline Beecham Corp Procedimiento e intermedios
DE60336149D1 (de) * 2002-08-16 2011-04-07 Immunogen Inc Vernetzer mit hoher reaktivität und löslichkeit und ihre verwendung bei der herstellung von konjugaten für die gezielte abgabe von kleinmolekularen arzneimitteln
CA2503490C (fr) 2002-10-21 2012-04-03 Allvivo, Inc. Revetement de surface pour dispositifs medicaux comprenant un compose bioactif
US7858108B2 (en) 2003-10-21 2010-12-28 Richard Nagler Elutable surface coating
CN101035802A (zh) * 2004-07-02 2007-09-12 健泰科生物技术公司 Iap抑制剂
KR101281501B1 (ko) 2004-12-09 2013-07-15 얀센 바이오테크 인코포레이티드 항인테그린 면역 컨쥬게이트, 방법 및 용도
KR20120127754A (ko) 2004-12-20 2012-11-23 제넨테크, 인크. Ｉａｐ의 피롤리딘 억제제
US20110166319A1 (en) * 2005-02-11 2011-07-07 Immunogen, Inc. Process for preparing purified drug conjugates
JP5165387B2 (ja) 2005-02-11 2013-03-21 イムノゲン インコーポレーティッド 安定な薬物複合体を調製するための方法
CA3000520C (fr) 2005-08-24 2023-04-04 Immunogen, Inc. Procede de preparation de conjugues maytansinoides-anticorps
NZ594746A (en) * 2005-12-19 2013-03-28 Genentech Inc Inhibitors of iap
US20070260041A1 (en) * 2006-05-03 2007-11-08 David Crich Allylic disulfide rearrangement and desulfurization method for the preparation of allylic sulfides
CN101605786A (zh) * 2006-12-19 2009-12-16 健泰科生物技术公司 细胞凋亡抑制剂的咪唑并吡啶抑制剂
TWI432212B (zh) * 2007-04-30 2014-04-01 Genentech Inc Ｉａｐ抑制劑
RU2010133548A (ru) * 2008-01-11 2012-02-20 Дженентек, Инк. (Us) Ингибиторы iap
CN102171209A (zh) 2008-08-02 2011-08-31 健泰科生物技术公司 Iap抑制剂
JP5784592B2 (ja) 2009-06-03 2015-09-24 イミュノジェン・インコーポレーテッド 抱合方法
EP2691155B1 (fr) 2011-03-29 2018-11-14 Immunogen, Inc. Préparation de conjugués de maytansinoïde anticorps par procédé en une étape
AU2013326881B2 (en) 2012-10-04 2018-08-02 Immunogen, Inc. Use of a PVDF membrane to purify cell-binding agent cytotoxic agent conjugates
WO2014210267A1 (fr) 2013-06-28 2014-12-31 Immunogen, Inc. Purification d'intermédiaires utilisés pour préparer des lieurs hétérobifonctionnels
KR102325753B1 (ko) 2019-12-20 2021-11-11 주식회사 포스코 흑색 도금 강판 및 그 제조방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2872450A (en) * 1955-12-06 1959-02-03 Bayer Ag Thio- and dithio-carboxylic acid esters and a process for their manufacture
US3950348A (en) * 1971-12-30 1976-04-13 Merck & Co., Inc. Process for preparing e-pyridyl-4-methyloxycarbonyllysine

Also Published As

Publication number Publication date
SE7702462L (sv) 1978-09-05
JPS61191675A (ja) 1986-08-26
FR2382450A1 (fr) 1978-09-29
DE2808523A1 (de) 1978-09-07
US4149003A (en) 1979-04-10
GB1597756A (en) 1981-09-09
DE2808523C2 (fr) 1987-11-19
JPS53130674A (en) 1978-11-14
JPS624368B2 (fr) 1987-01-30
SE430062B (sv) 1983-10-17
JPS6121227B2 (fr) 1986-05-26

Similar Documents

Publication Publication Date Title
FR2382450B1 (fr)
DE2828666C2 (fr)
DE2713494B2 (fr)
DE2827012C3 (fr)
FR2376734B3 (fr)
AU3353778A (fr)
DE2726310C2 (fr)
FR2376440B3 (fr)
DE2707865C2 (fr)
FR2377427B1 (fr)
AR210643A1 (fr)
AU495917B2 (fr)
DE7716473U1 (fr)
AU71461S (fr)
BG24331A1 (fr)
BE871419A (fr)
BG25812A1 (fr)
BG25811A1 (fr)
BG25810A1 (fr)
BG25809A1 (fr)
BG25808A1 (fr)
BG25815A1 (fr)
BG24713A1 (fr)
BG25819A1 (fr)
BG25820A1 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse